Improvement of dyskinesias with l-dopa infusion in advanced Parkinson's disease.
Research output: Contribution to journal › Article
We wanted to investigate whether continuous intrajejunal levodopa-carbidopa intestinal gel (LCIG) therapy has an antidyskinetic effect in patients with Parkinson's disease (PD) and troublesome dyskinesias. We also sought to examine the effect of LCIG therapy on motor function and health-related quality of life (HRQoL).
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Acta Neurologica Scandinavica|
|Early online date||2015 Sep 11|
|Publication status||Published - 2015|